Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs Cannabis Investing News
Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19 Pharmaceutical Investing
Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19 Pharmaceutical Investing
Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19 Pharmaceutical Investing
Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials Pharmaceutical Investing
Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment Cannabis Investing News
Revive Therapeutics Explores the use of Bucillamine as a Novel Treatment for Infectious Diseases Including COVID-19 Cannabis Investing News
